TP is recognized for combining AI orchestration, operational excellence, regional scale, and customer-centric innovation to transform customer experience management services across the region. SAN ANTONIO, Sept. 10, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that TP has...
Basel, 10 September 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for Enspryng® (satralizumab) for the treatment of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). The filing acceptance is based on positive results from the Phase III METEOROID study, which showed that Enspryng provided consistent, clinically meaningful improvements for people living with MOGAD. 1 This marks the second FDA Priority Review for Enspryng, following the one granted for thyroid eye disease (TED) in June 2026. The FDA is expected to make a decision on approval in MOGAD by 10 January 2027.
WISeKey Shareholders Approve Redomiciliation to the British Virgin Islands at Extraordinary General Meeting
Dallas, Texas--(Newsfile Corp. - September 10, 2026) - Gordon Highlander, a premier commercial general contractor specializing in design-build and engineered construction solutions, is launching its East Region operations in Jacksonville, Florida. The expansion will be led by Senior Vice President Gavin Finley, an accomplished construction executive with more than 15 years of experience delivering large-scale industrial and commercial projects throughout the region.More information is available...
MKS Disability Services has expanded its in-home NDIS Disability Services Provider in Melbourne for people with disability across Melbourne. The team knows that each person [read full press release...]
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 10, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..
Ce financement permettra d'accélérer l'expansion mondiale, le développement de produits et le déploiement de ZeroRisk auprès des principaux prestataires de paiement. ZeroRisk entend s'imposer comme leader sur le segment émergent de la gestion des risques dans le secteur du traitement des...
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 10, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ:CAPR) securities. If you suffered a loss on your Capricor Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Capricor Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 10, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..
PITTSBURGH, 10. September 2026 /PRNewswire/ -- MSA Safety hat die Markteinführung des A1X™ angekündigt, seines neuesten WinGrip® Vakuumankers, der dazu beitragen soll, die Flugzeugwartung sicherer, schneller und vielseitiger zu gestalten. Der WinGrip-Vakuumanker® A1X™ stellt die neueste...
NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Coach presented its Spring 2027 collection this evening in downtown New York City. Marking the house's 85th anniversary, the runway brought together slim, straight silhouettes, loveworn materials and refined tailoring, alongside inside-out...
As interest in daily respiratory wellness support continues in 2026, this BreathEaseX review examines the brand-stated six-ingredient spray formula, current standalone pricing, changed bottle counts, 60-day guarantee, and the factors buyers may want to compare when deciding whether the product fits their routine.